ProPhase Labs Just Filed Its Quarterly Report: Note 7 – Earnings (...

Note 7 – Earnings (Loss) Per Share
 
Basic earnings (loss) per share is computed by dividing net income or loss attributable to common stockholders by the weighted-average number of shares of our C ommon Stock outstanding for the period. Diluted earnings (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue Common Stock were exercised or converted into Common Stock or resulted in the issuance of Common Stock that shared in the earnings of the entity. Diluted earnings per share also utilize the treasury stock method which prescribes a theoretical buy-back of shares from the theoretical proceeds of all options and warrants outstanding during the period. Options and warrants outstanding to acquire shares of our Common Stock at June 30, 2014 and 2013 were 1,632,500 and 1,301,500, respectively.
 
For the three and six months ended June 30, 2014 and 2013 dilutive earnings per share is the same as basic earnings per share due to (i) the inclusion of Common Stock, in the form of stock options and warrants (“Common Stock Equivalents”), would have an anti-dilutive effect on the loss per share or (ii) there were no Common Stock Equivalents for the respective period. For the three months ended June 30, 2014 and 2013, there were 559,318 and 359,271 Common Stock Equivalents, respectively, which were in the money, that were excluded from the earnings per share computation. For the six months ended June 30, 2014 and 2013, there were 571,736 and 401,849 Common Stock Equivalents, respectively, which were in the money, that were excluded from the earnings per share computation.
 
A reconciliation of the applicable numerators and denominators of the income statement periods presented, as reflected in the results of continuing operations, is as follows (in thousands, except per share amounts):
 
 
 
Three Months Ended
 
 
Three Months Ended
 
 
Six Months Ended
 
 
Six Months Ended
 
 
 
June 30, 2014
 
 
June 30, 2013
 
 
June 30, 2014
 
 
June 30, 2013
 
 
 
Loss
 
 
Shares
 
 
EPS
 
 
Loss
 
 
Shares
 
 
EPS
 
 
Loss
 
 
Shares
 
 
EPS
 
 
Loss
 
 
Shares
 
 
EPS
 
Basic earnings
(loss) per share
 
($
3,138
)
 
 
16,944
 
 
($
0.19
)
 
($
1,719
)
 
 
15,845
 
 
($
0.11
)
 
($
3,942
)
 
 
16,709
 
 
($
0.24
)
 
($
1,429
)
 
 
15,799
 
 
($
0.09
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilutives:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diluted income(loss) per share
 
($
3,138
)
 
 
16,944
 
 
($
0.19
)
 
($
1,719
)
 
 
15,845
 
 
($
0.11
)
 
($
3,942
)
 
 
16,709
 
 
($
0.24
)
 
($
1,429
)
 
 
15,799
 
 
($
0.09
)

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!

Other recent filings from the company include the following:

ProPhase Labs's Chief Financial Officer just picked up 360,000 shares - Sept. 15, 2017
Tender offer statement by Issuer - Aug. 25, 2017

Auto Refresh

Feedback